Sleep disturbances and depression: a challenge for antidepressants.
about
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulationUpdate of sleep alterations in depressionAgomelatine, an innovative pharmacological response to unmet needsKetamine influences CLOCK:BMAL1 function leading to altered circadian gene expressionBlockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways[The newer sedative-hypnotics].Could agomelatine be the ideal antidepressant?Nutrient- and non-nutrient-based natural health product (NHP) use in adults with mood disorders: prevalence, characteristics and potential for exposure to adverse eventsMelatonin and melatonergic drugs on sleep: possible mechanisms of action.Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment.Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.Sleep homeostasis in alcohol-dependent, depressed and healthy control men.Treatments in depression.Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.Emerging treatments for major depression.Mood disorders, circadian rhythms, melatonin and melatonin agonists.The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis.Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.Disruption of circadian rhythms: a crucial factor in the etiology of depression.Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.Role of melatonin in mood disorders and the antidepressant effects of agomelatine.New insights on the antidepressant discontinuation syndrome.Depressive symptoms are associated with poor sleep quality rather than apnea-hypopnea index or hypoxia during sleep in patients with obstructive sleep apnea.Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT).Antagonistic Serotonergic and Octopaminergic Neural Circuits Mediate Food-Dependent Locomotory Behavior in Caenorhabditis elegans.Does quality of sleep mediate the effect of depression on hopelessness?How is sleep quality affected by the psychological and symptom distress of advanced cancer patients?Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study.Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramineHippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress.Association between nonmedical use of prescription drugs and sleep quality in a large college student sample.Patients attitudes towards sleep disturbances during chemotherapy.NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depression.Social jetlag and depression status: Results obtained from the Netherlands Study of Depression and Anxiety.Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study.Therapeutic potential of melatonin agonists
P2860
Q22305782-398D6943-E456-4A04-A1D1-7920D053B4E7Q26781426-F32CCB5C-7CD6-474A-89F8-BD1A9526F79BQ28292143-089E8788-F3D1-47F1-9311-AA4DBF4DE96EQ28476686-323722AA-B515-43CF-A38A-9A17C44EC60CQ33595018-9AD8233B-E151-4BDB-B7C4-3DB27B02A278Q34143490-BDD1090F-C298-409D-BE24-9AABB304E184Q34572999-C8BA209C-B296-4309-8B71-4F6C811CC35AQ34660563-36420DA0-1B1E-437E-A6F4-71695C9EDF6FQ34970081-906792DF-691D-4F32-AF00-BB227753BAD0Q35101395-80434B1E-E4B1-433F-86F5-E0F229D65092Q35122330-3541F1ED-89F6-42E1-8EC0-C6219FE0A15DQ35167054-2ADDA607-616D-4B7B-9B61-EE86BCCEEEC3Q35236696-71F4F7AA-87D1-4049-9BC2-F538856FF8CEQ35276597-8A38E783-0385-4EFC-AF52-6ACF9377E1EEQ35744195-5B6569A2-3E46-42DA-AAF5-DCC7A2449A8BQ36730674-A1EA2D3C-E24E-4A50-8E78-84FFB484B6A5Q36748061-6787C77E-398A-4AEE-94B1-CE4F13E623E6Q37210115-60BC621A-9F8E-4535-B741-06819363901EQ37248971-7152D29A-5286-40E2-BDF7-8B844788E52DQ37405307-B3E67343-5805-40C6-AEC0-9E32BB0326F0Q37918401-116D6887-47D1-4AFB-9677-343349B12E8BQ37945726-5D823FCB-9999-492F-9BC0-66DD2CD724AFQ38033191-DF1BED10-B25B-44A2-8308-774F3ABDA5C0Q38238790-A510B282-E8E8-4ADE-B41E-C4CDCEA68935Q38616448-14B9EC8C-EB75-4E75-90FE-F6A3033A6667Q38637946-6FE19E64-AE95-4906-A17A-459E9B534CE7Q38683328-DCC38837-A2E3-4F99-959F-DC3C79F42B26Q39300392-BE5C47D1-B7B5-4AE0-A2F5-F8C54A728509Q39313582-795CCA74-B97F-4EF2-A513-E8F783C95801Q40540771-13A6665B-7783-437B-9C04-A1B8E92301EAQ41017682-DD97BDBF-B59D-41F2-B6DF-4CE63573FE5BQ42015698-4C88B797-8ECE-4F3F-9580-4CBA34CD92A3Q44491325-38CFC3D2-6330-4549-ADB7-33ED44A532B1Q45072797-2282BD52-5A96-4D5E-B067-042F2365D8D8Q45986916-75DFC4E7-E3D0-4326-8FA0-7C4405C25559Q46238722-8F1C2DC8-A4F0-4B9E-A343-358222BBC5ADQ47094645-2D224710-5338-45C2-B36E-9EB8650F131DQ47390165-48760343-A3BF-45A2-BD06-0A2531F86BFDQ58425005-4F688422-EFEB-41A2-862E-5B331E95341F
P2860
Sleep disturbances and depression: a challenge for antidepressants.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Sleep disturbances and depression: a challenge for antidepressants.
@ast
Sleep disturbances and depression: a challenge for antidepressants.
@en
type
label
Sleep disturbances and depression: a challenge for antidepressants.
@ast
Sleep disturbances and depression: a challenge for antidepressants.
@en
prefLabel
Sleep disturbances and depression: a challenge for antidepressants.
@ast
Sleep disturbances and depression: a challenge for antidepressants.
@en
P1476
Sleep disturbances and depression: a challenge for antidepressants.
@en
P356
10.1097/01.YIC.0000195658.91524.61
P478
21 Suppl 1
P577
2006-02-01T00:00:00Z